DTC Advertising Blogs

10|02|25

Unpacking the FDA’s Double Standard

In her latest op-ed for MM+M, Susan Perlbachs, Chief Creative Officer, delivers a powerful reflection on the FDA’s recent wave of untitled and warning letters—and the broader implications for how pharma is scrutinized compared to other industries. Read more.